María Guadalupe Sánchez‐Parada

Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

Lucia Flores-Contreras, Ana Sandoval-Rodríguez, Mayra Marta Mena Múgica et al. · BMC Gastroenterology · 2014 · 79 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

A Controlled Clinical Trial With Pirfenidone in the Treatment of Pathological Skin Scarring Caused by Burns in Pediatric Patients

Juan Armendáriz‐Borunda, Iván Lyra-González, David Medina-Preciado et al. · Annals of Plastic Surgery · 2011 · 61 citations

Medicine, Pediatrics, Pharmacotherapy +15

Controlled Clinical Trial With Pirfenidone in the Treatment of Breast Capsular Contracture

Evelin Rosaira Veras-Castillo, Lázaro Cárdenas-Camarena, Iván Lyra-González et al. · Annals of Plastic Surgery · 2011 · 37 citations

Medicine, Pharmacotherapy, Plastic Surgery +8

Pirfenidone Accelerates Wound Healing in Chronic Diabetic Foot Ulcers: A Randomized, Double-Blind Controlled Trial

Luz Elena Gasca-Lozano, Silvia Lucano‐Landeros, Héctor Ruiz-Mercado et al. · Journal of Diabetes Research · 2017 · 32 citations · Full text

Health Professions, Pharmacology, Pharmacotherapy +17

In vivo evaluation of the genotoxicity and oxidative damage in individuals exposed to 10% hydrogen peroxide whitening strips

José Francisco Del Real García, Fausto Rubén Saldaña-Velasco, Susana Vanessa Sánchez-de la Rosa et al. · Clinical Oral Investigations · 2018 · 24 citations

Pharmacy, Toxicology, Molecular Toxicology +11